These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36545037)

  • 41. Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial.
    Zeifman RJ; Singhal N; Dos Santos RG; Sanches RF; de Lima Osório F; Hallak JEC; Weissman CR
    Psychopharmacology (Berl); 2021 Feb; 238(2):453-459. PubMed ID: 33118052
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers.
    Riba J; Anderer P; Morte A; Urbano G; Jané F; Saletu B; Barbanoj MJ
    Br J Clin Pharmacol; 2002 Jun; 53(6):613-28. PubMed ID: 12047486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects.
    Aicher HD; Mueller MJ; Dornbierer DA; Suay D; Elsner C; Wicki I; Meling D; Caflisch L; Hempe A; Steinhart C; Mueller J; Von Rotz R; Kleim B; Scheidegger M
    Front Psychiatry; 2023; 14():1302559. PubMed ID: 38264636
    [TBL] [Abstract][Full Text] [Related]  

  • 44. BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: results from a factorial, randomized, sham-controlled trial.
    Brunoni AR; Machado-Vieira R; Zarate CA; Vieira EL; Vanderhasselt MA; Nitsche MA; Valiengo L; Benseñor IM; Lotufo PA; Gattaz WF; Teixeira AL
    Eur Neuropsychopharmacol; 2014 Jul; 24(7):1144-51. PubMed ID: 24702987
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of Zishen pingchan granules combined with pramipexole on serum BDNF, IL-1β, IL-6, CRP, TNF-α levels in depressed patients with Parkinson's disease: Results of a randomized, double-blind, controlled study.
    Ning H; Zhou H; Yang N; Ren J; Wang H; Liu W; Zhao Y
    Exp Gerontol; 2023 Oct; 182():112295. PubMed ID: 37734668
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats.
    Uthaug MV; Mason NL; Toennes SW; Reckweg JT; de Sousa Fernandes Perna EB; Kuypers KPC; van Oorsouw K; Riba J; Ramaekers JG
    Psychopharmacology (Berl); 2021 Jul; 238(7):1899-1910. PubMed ID: 33694031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Impact of Ayahuasca on Suicidality: Results From a Randomized Controlled Trial.
    Zeifman RJ; Palhano-Fontes F; Hallak J; Arcoverde E; Maia-Oliveira JP; Araujo DB
    Front Pharmacol; 2019; 10():1325. PubMed ID: 31798447
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities.
    Soler J; Elices M; Franquesa A; Barker S; Friedlander P; Feilding A; Pascual JC; Riba J
    Psychopharmacology (Berl); 2016 Mar; 233(5):823-9. PubMed ID: 26612618
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacology of ayahuasca administered in two repeated doses.
    Dos Santos RG; Grasa E; Valle M; Ballester MR; Bouso JC; Nomdedéu JF; Homs R; Barbanoj MJ; Riba J
    Psychopharmacology (Berl); 2012 Feb; 219(4):1039-53. PubMed ID: 21842159
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial.
    Rocha JM; Rossi GN; de Lima Osório F; Bouso JC; de Oliveira Silveira G; Yonamine M; Campos AC; Bertozi G; Cecílio Hallak JE; Dos Santos RG
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):267-274. PubMed ID: 33843820
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychedelics and Neuroplasticity: A Systematic Review Unraveling the Biological Underpinnings of Psychedelics.
    de Vos CMH; Mason NL; Kuypers KPC
    Front Psychiatry; 2021; 12():724606. PubMed ID: 34566723
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum levels of brain-derived neurotrophic factor are unchanged after transcranial direct current stimulation in treatment-resistant depression.
    Palm U; Fintescu Z; Obermeier M; Schiller C; Reisinger E; Keeser D; Pogarell O; Bondy B; Zill P; Padberg F
    J Affect Disord; 2013 Sep; 150(2):659-63. PubMed ID: 23664268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ceremonial Ayahuasca in Amazonian Retreats-Mental Health and Epigenetic Outcomes From a Six-Month Naturalistic Study.
    Ruffell SGD; Netzband N; Tsang W; Davies M; Butler M; Rucker JJH; Tófoli LF; Dempster EL; Young AH; Morgan CJA
    Front Psychiatry; 2021; 12():687615. PubMed ID: 34177670
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychedelic Therapy: A Primer for Primary Care Clinicians-N,N-Dimethyltryptamine and Ayahuasca.
    Shinozuka K; Tabaac BJ; Arenas A; Beutler BD; Cherian K; Evans VD; Fasano C; Muir OS
    Am J Ther; 2024 Mar-Apr 01; 31(2):e112-e120. PubMed ID: 38518268
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Emotion regulation effects of Ayahuasca in experienced subjects during implicit aversive stimulation: An fMRI study.
    Arruda Sanchez T; Ramos LR; Araujo F; Schenberg EE; Yonamine M; Lobo I; de Araujo DB; Luna LE
    J Ethnopharmacol; 2024 Feb; 320():117430. PubMed ID: 37979818
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased frontal and paralimbic activation following ayahuasca, the pan-Amazonian inebriant.
    Riba J; Romero S; Grasa E; Mena E; Carrió I; Barbanoj MJ
    Psychopharmacology (Berl); 2006 May; 186(1):93-8. PubMed ID: 16575552
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
    Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
    Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of macular xanthophyll supplementation on brain-derived neurotrophic factor, pro-inflammatory cytokines, and cognitive performance.
    Stringham NT; Holmes PV; Stringham JM
    Physiol Behav; 2019 Nov; 211():112650. PubMed ID: 31425700
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychosocial and Drug Use Assessment of Regular vs. Non-Regular Ayahuasca Users in a Brazilian Sample: a Web-Based Survey.
    Daldegan-Bueno D; Révész D; Morais PR; Barbosa PCR; Maia LO
    Subst Use Misuse; 2022; 57(7):1072-1081. PubMed ID: 35466853
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.